Abstract: Several types of metal nanoparticles are capable of converting energy, such as that carried by near-infrared light or an oscillating magnetic field, into heat at a level high enough to kill tumors.
Now, a recently completed Phase I clinical trial in patients with recurrent prostate cancer has shown that magnetic nanoparticles can be safely administered to humans and will produce localized tumor-killing temperatures when stimulated by an oscillating magnetic field.